WHO/Malin Bring
© Credits

Obesity

    Overview

    Obesity is one of the greatest public health challenges of the 21st century. Both societies and governments need to act to curb the epidemic. National policies should encourage and provide opportunities for greater physical activity, and improve the affordability, availability and accessibility of healthy foods. They should also encourage the involvement of different government sectors, civil society, the private sector and other stakeholders.

    Impact
    Obesity prevalence has tripled in many countries of the WHO European Region since the 1980s, and the numbers of those affected continue to rise at an alarming rate, particularly among children. In addition to causing various physical disabilities and psychological problems, excess weight drastically increases a person's risk of developing a number of noncommunicable diseases (NCDs), including cardiovascular disease, cancer and diabetes. The risk of developing more than one of these diseases (co-morbidity) also increases with increasing body weight. Obesity is already responsible for 2–8% of health costs and 10–13% of deaths in different parts of the Region.


    WHO response

    A primary aim of WHO/Europe is to monitor and address the causes of preventable illness, as well as the underlying factors contributing to their increase – such as the behavioural and socioeconomic factors leading to obesity. In the fields of physical activity and diet, the Regional Office's support to countries is guided by the Global status report on noncommunicable diseases 2014, the WHO European Food and Nutrition Action Plan 2015–2020, and Rome Declaration on Nutrition.

    To identify the underlying social causes of obesity and other noncommunicable diseases and their common risk factors, WHO/Europe commissioned a review of the social determinants of health throughout all 53 Member States, which took place from 2010 to 2012. This review provided the Action Plan for implementation of the European Strategy for the Prevention and Control of Noncommunicable Diseases 2012−2016, which identifies priority action areas and interventions for Member States to focus on until 2016.

    Our work

    All →

    Multimedia

    All →

    Publications

    All →
    Avoidable mortality, risk factors and policies for tackling noncommunicable diseases – leveraging data for impact: monitoring commitments in the WHO European Region ahead of the Fourth United Nations High-Level Meeting

    Noncommunicable diseases (‎NCDs)‎, such as cardiovascular diseases, cancers, diabetes and chronic respiratory diseases, remain the leading cause...

    WHO European Childhood Obesity Surveillance Initiative (‎COSI)‎ in Ukraine 2023–2024

    The WHO European COSI is the largest childhood obesity surveillance initiative, tracking trends in overweight and obesity among primary school-aged children....

    Evaluation of brief intervention delivery by primary-care providers in the WHO European Region: BRIEF project

    Brief interventions are recognized by WHO as effective for addressing the risk factors of noncommunicable diseases (NCDs), including smoking, alcohol consumption,...

    Policy brief on the association between sugar-sweetened beverage consumption and childhood overweight and obesity

    Childhood overweight and obesity represent a significant global health challenge. Alongside the rising prevalence of this issue is sugar-sweetened beverage...

    Documents

    All →

    The clock is ticking. With just five years left to achieve 2030 Sustainable Development Goal (SDG) 3.4 of reducing premature deaths from noncommunicable...

    The WHO European Childhood Obesity Surveillance Initiative (COSI) was established in 2007 to meet the need for standardized data on the prevalence of overweight...

    One of the WHO-recommended policy actions for creating active people is to integrate physical activity services – such as physical activity referral...

    TB remains an important cause of mortality and morbidity in the WHO European Region and worldwide. Rates of drug-resistant TB are increasing globally....